[PDF][PDF] Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation)

…, JA Heit, MF Mulroy, RW Rosenquist… - … and pain medicine, 2003 - sarasotaanesthesia.com
Neuraxial anesthesia and analgesia provide sev-eral advantages over systemic opioids,
including superior analgesia, reduced blood loss and need for transfusion, decreased …

Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society

R Chou, JD Loeser, DK Owens, RW Rosenquist… - Spine, 2009 - journals.lww.com
Study Design. Clinical practice guideline. Objective. To develop evidence-based
recommendations on use of interventional diagnostic tests and therapies, surgeries, and …

ASRA practice advisory on local anesthetic systemic toxicity

…, MR Hejtmanek, MF Mulroy, RW Rosenquist… - Regional Anesthesia & …, 2010 - rapm.bmj.com
The American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local
Anesthetic Systemic Toxicity assimilates and summarizes current knowledge regarding the …

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based …

…, JA Heit, MF Mulroy, RW Rosenquist… - Regional Anesthesia & …, 2010 - rapm.bmj.com
The actual incidence of neurologic dysfunction resulting from hemorrhagic complications
associated with neuraxial blockade is unknown. Although the incidence cited in the literature is …

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

…, F Granath, AI Catrina, R Rosenquist… - Arthritis & …, 2006 - Wiley Online Library
Objective Chronic inflammatory conditions such as rheumatoid arthritis (RA) have been
associated with malignant lymphomas. This study was undertaken to investigate which patients …

Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline

R Chou, SJ Atlas, SP Stanos, RW Rosenquist - Spine, 2009 - journals.lww.com
Study Design. Systematic review. Objective. To systematically assess benefits and harms of
nonsurgical interventional therapies for low back and radicular pain. Summary of …

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

…, E Boveri, R Invernizzi, R Rosenquist… - Blood, The Journal …, 2015 - ashpublications.org
Refractory anemia with ring sideroblasts (RARS) is a myelodysplastic syndrome (MDS)
characterized by isolated erythroid dysplasia and 15% or more bone marrow ring sideroblasts. …

[HTML][HTML] Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia

…, P Watson, M Jansen, Y Yoshinaga, R Rosenquist… - Cell, 2007 - cell.com
The heritability of B cell chronic lymphocytic leukemia (CLL) is relatively high; however, no
predisposing mutation has been convincingly identified. We show that loss or reduced …

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

…, C Belessi, F Davi, R Rosenquist… - Blood, The Journal …, 2012 - ashpublications.org
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into
distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However, …

Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia

…, C Sundström, G Roos, R Rosenquist - Blood, The Journal …, 2002 - ashpublications.org
Recent studies on the immunoglobulin variable heavy chain (IgV H ) genes have revealed
that B-cell chronic lymphocytic leukemia (B-CLL) consists of at least 2 clinical entities with …